EGFR and breast carcinoma: It could also be a substrate for membrane-bound members of the ADAM (a disintegrin and metalloproteinase) domain family of proteins, some of them reported to be expressed in several cancers, including the breast cancer, in which they may release ERBB ligands and promote proliferation (for review, see Mochizuki and Okada, 2007).